Is CHD a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Church & Dwight (CHD) rests on Power-brand and personal-care mix: A concentrated set of power brands (Arm & Hammer, OxiClean, Trojan, Batiste, TheraBreath, Waterpik, Hero Cosmetics) generates most of the revenue, and the faster-growing personal-care names give CHD a higher-growth tilt than a pure household-products company. Revenue (TTM) is ~$6.2B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: U.S. Whether CHD is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Church & Dwight is an American consumer packaged goods company headquartered in Ewing, New Jersey, that makes household, personal-care and specialty products. It sells more than 80 brands, but roughly a dozen "power brands" (Arm & Hammer, OxiClean, Trojan, Nair, First Response, Orajel, Batiste, Waterpik, TheraBreath, Hero Cosmetics and others) drive the bulk of revenue. The mix blends slow-and-steady staples like baking soda and laundry additives with faster-growing personal-care acquisitions, and the company has a long track record of bolt-on M&A and consistent dividend increases. The investment picture is that of a defensive compounder. CHD posts modest but reliable organic growth, expanding gross margins from productivity programs, and strong free cash flow, which supports buybacks and a multi-decade dividend history. The tension is valuation: the stock trades around 30x earnings, a premium to the household-products group, at a time when U.S. organic growth has been soft and the 2026 plan leans on new-product launches and back-half execution. Bulls point to margin gains and the personal-care pivot, while skeptics see a stretched multiple against muted domestic demand and heavy competition from far larger rivals.
What's the case for buying CHD?
1. Power-brand and personal-care mix
A concentrated set of power brands (Arm & Hammer, OxiClean, Trojan, Batiste, TheraBreath, Waterpik, Hero Cosmetics) generates most of the revenue, and the faster-growing personal-care names give CHD a higher-growth tilt than a pure household-products company. Continued innovation, notably around TheraBreath toothpaste, is central to the 2026 growth story.
2. Margin expansion and productivity
Adjusted gross margin expanded about 130 basis points to roughly 46.4% in Q1 2026 as productivity programs, acquisitions and favorable FX more than offset inflation and tariff costs. Sustained gross-margin gains are a key lever for the 5% to 8% adjusted EPS growth the company targets for 2026.
3. Cash generation and shareholder returns
CHD guides to roughly $1.15 billion of free cash flow in 2026, funding a long-running dividend (a dividend aristocrat with decades of increases) plus buybacks and bolt-on acquisitions. The forward dividend is about $1.23 per share for a yield near 1.3%.
4. Bolt-on M&A engine
Acquisitions like Waterpik, TheraBreath, Hero Cosmetics and Touchland have historically refreshed the portfolio toward higher-growth categories. Continued disciplined dealmaking is part of how management aims to offset slower legacy-brand growth.
What are the risks to CHD?
U.S. organic growth has been soft, with some domestic categories declining, so 2026 guidance is back-half weighted and carries execution risk on new-product launches. At around 30x trailing earnings, the valuation is a premium to the household-products group and leaves little margin for error if volumes or margins disappoint. The company competes with far larger rivals such as Procter & Gamble and Colgate-Palmolive that have bigger marketing budgets and shelf presence. Input-cost inflation, tariffs and private-label competition can pressure margins, and CHD faces routine product-related consumer litigation typical of large CPG companies. A separate SEC proxy-disclosure matter involving a former CEO was settled in 2024 and is not an active securities-fraud case.
How is CHD valued? (as of July 2026)
Snapshot for CHD as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$6.2B
- Market cap: ~$23B
- P/E (TTM): ~32x
- EPS (TTM): ~$3.04
- Dividend yield: ~1.3%
- 2026 FCF guide: ~$1.15B
Q1 2026 net sales were about $1.47 billion (up 0.2%), with organic sales up 5.0% and adjusted EPS of $0.95, both ahead of the company outlook. Management targets roughly 3% to 4% organic growth and 5% to 8% adjusted EPS growth for 2026. The premium multiple reflects CHD's defensive profile and margin expansion, but it also assumes steady execution against soft domestic demand.
How do you decide if CHD is a buy?
Rather than asking whether CHD is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold CHD indirectly through an index or sector ETF before adding more.
For the full picture, see the CHD stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CHD against your real portfolio and see your actual exposure before deciding.
The bottom line on CHD
The bottom line: Church & Dwight's story right now is Power-brand and personal-care mix, with revenue (ttm) at ~$6.2B. If you believe that narrative continues, the call is about sizing CHD sensibly and checking overlap with what you own; if you doubt it (the risk: u.S.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
More on CHD
- CHD stock guide (what the company does, ETFs that hold it, similar stocks, and the themes it fits)
- CHD stock forecast (the drivers and risks shaping the outlook)
- Does CHD pay a dividend?
Build a basket around CHD with Walnut
Use Church & Dwight as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is CHD a good stock to buy right now?
+
The case for Church & Dwight right now is Power-brand and personal-care mix, with revenue (ttm) at ~$6.2B. If you believe that thesis holds, CHD is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is u.S. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Church & Dwight do?
+
Church & Dwight is an American consumer packaged goods company headquartered in Ewing, New Jersey, that makes household, personal-care and specialty products.
What are the main risks of CHD?
+
U.S. organic growth has been soft, with some domestic categories declining, so 2026 guidance is back-half weighted and carries execution risk on new-product launches. At around 30x trailing earnings, the valuation is a premium to the household-products group and leaves little margin for error if volumes or margins disappoint. The company competes with far larger rivals such as Procter & Gamble and Colgate-Palmolive that have bigger marketing budgets and shelf presence. Input-cost inflation, tariffs and private-label competition can pressure margins, and CHD faces routine product-related consumer litigation typical of large CPG companies. A separate SEC proxy-disclosure matter involving a former CEO was settled in 2024 and is not an active securities-fraud case.
What does Church & Dwight do?
+
It is a consumer packaged goods company that makes household, personal-care and specialty products. Its best-known brands include Arm & Hammer, OxiClean, Trojan, Nair, First Response, Orajel, Batiste, Waterpik and TheraBreath.
Is CHD a dividend stock?
+
Yes. Church & Dwight has a decades-long record of paying and raising its dividend, making it a dividend aristocrat. The forward dividend is around $1.23 per share, a yield near 1.3%, paid quarterly.
Why does CHD trade at a high P/E?
+
The stock carries a premium multiple (around 30x earnings) because investors value its defensive staples profile, consistent free cash flow, margin expansion and long dividend history. That premium also assumes steady execution.
What are Church & Dwight's power brands?
+
Although CHD sells more than 80 brands, roughly a dozen power brands generate most of the revenue, including Arm & Hammer, OxiClean, Trojan, Nair, First Response, Orajel and Batiste, plus acquired growth brands like Waterpik, TheraBreath and Hero Cosmetics.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell CHD; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.